Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 24 entries
Sorted by: Best Match Show Resources per page
Can we lower our maternal mortality rate?.

Laval medical

MARCHAND R.
PMID: 18146011
Laval Med. 1949 Jun;14(6):758-64.

No abstract available.

Cite
MARCHAND R. Pouvons-nous diminuer notre taux de mortalité maternelle? Can we lower our maternal mortality rate?. Laval Med. 1949;14(6):758-64
MARCHAND, R. (1949). Pouvons-nous diminuer notre taux de mortalité maternelle? Can we lower our maternal mortality rate?. Laval medical, 14(6), 758-64.
MARCHAND, R. "Pouvons-nous diminuer notre taux de mortalité maternelle?" Can we lower our maternal mortality rate?. Laval medical vol. 14,6 (1949): 758-64.
MARCHAND R. Pouvons-nous diminuer notre taux de mortalité maternelle? Can we lower our maternal mortality rate?. Laval Med. 1949 Jun;14(6):758-64. French. PMID: 18146011.
Copy Download .nbib Format: NLM
Treatment of pancreatic cancer: what can we really predict today?.

Cancers

Bachet JB, Marechal R, Van Laethem JL.
PMID: 24212636
Cancers (Basel). 2011 Feb 17;3(1):675-99. doi: 10.3390/cancers3010675.

Managing pancreatic cancer remains a big challenge due to its worse course and prognosis. However, therapeutic options and multimodal strategies are increasing nowadays, including new agents, new regimens and chemoradiation. Recently, the FOLFIRINOX regimen has been reported to be...

Cite
Bachet JB, Marechal R, Van Laethem JL. Treatment of pancreatic cancer: what can we really predict today?. Cancers (Basel). 2011;3(1):675-99doi: 10.3390/cancers3010675.
Bachet, J. B., Marechal, R., & Van Laethem, J. L. (2011). Treatment of pancreatic cancer: what can we really predict today?. Cancers, 3(1), 675-99. https://doi.org/10.3390/cancers3010675
Bachet, Jean-Baptiste, et al. "Treatment of pancreatic cancer: what can we really predict today?." Cancers vol. 3,1 (2011): 675-99. doi: https://doi.org/10.3390/cancers3010675
Bachet JB, Marechal R, Van Laethem JL. Treatment of pancreatic cancer: what can we really predict today?. Cancers (Basel). 2011 Feb 17;3(1):675-99. doi: 10.3390/cancers3010675. PMID: 24212636; PMCID: PMC3756384.
Copy Download .nbib Format: NLM
High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation.

International journal of molecular sciences

Bonnet-Magnaval F, Diallo LH, Brunchault V, Laugero N, Morfoisse F, David F, Roussel E, Nougue M, Zamora A, Marchaud E, Tatin F, Prats AC, Garmy-Susini B, DesGroseillers L, Lacazette E.
PMID: 35008641
Int J Mol Sci. 2021 Dec 25;23(1). doi: 10.3390/ijms23010215.

Stau1 is a pluripotent RNA-binding protein that is responsible for the post-transcriptional regulation of a multitude of transcripts. Here, we observed that lung cancer patients with a high Stau1 expression have a longer recurrence free survival. Strikingly, Stau1 did...

Cite
Bonnet-Magnaval F, Diallo LH, Brunchault V, et al. High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010215.
Bonnet-Magnaval, F., Diallo, L. H., Brunchault, V., Laugero, N., Morfoisse, F., David, F., Roussel, E., Nougue, M., Zamora, A., Marchaud, E., Tatin, F., Prats, A. C., Garmy-Susini, B., DesGroseillers, L., & Lacazette, E. (2021). High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010215
Bonnet-Magnaval, Florence, et al. "High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010215
Bonnet-Magnaval F, Diallo LH, Brunchault V, Laugero N, Morfoisse F, David F, Roussel E, Nougue M, Zamora A, Marchaud E, Tatin F, Prats AC, Garmy-Susini B, DesGroseillers L, Lacazette E. High Level of Staufen1 Expression Confers Longer Recurrence Free Survival to Non-Small Cell Lung Cancer Patients by Promoting THBS1 mRNA Degradation. Int J Mol Sci. 2021 Dec 25;23(1). doi: 10.3390/ijms23010215. PMID: 35008641.
Copy Download .nbib Format: NLM
hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status.

Cancers

Raffenne J, Nicolle R, Puleo F, Le Corre D, Boyez C, Marechal R, Emile JF, Demetter P, Bardier A, Laurent-Puig P, de Mestier L, Paradis V, Couvelard A, VanLathem JL, MacKey JR, Bachet JB, Svrcek M, Cros J.
PMID: 31752123
Cancers (Basel). 2019 Nov 18;11(11). doi: 10.3390/cancers11111808.

Gemcitabine is still one of the standard chemotherapy regimens for pancreatic ductal adenocarcinoma (PDAC). Gemcitabine uptake into tumor cells is mainly through the human equilibrative nucleoside transport 1 (hENT1). It was therefore proposed as a potential predictive biomarker of...

Cite
Raffenne J, Nicolle R, Puleo F, et al. hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. Cancers (Basel). 2019;11(11)doi: 10.3390/cancers11111808.
Raffenne, J., Nicolle, R., Puleo, F., Le Corre, D., Boyez, C., Marechal, R., Emile, J. F., Demetter, P., Bardier, A., Laurent-Puig, P., de Mestier, L., Paradis, V., Couvelard, A., VanLathem, J. L., MacKey, J. R., Bachet, J. B., Svrcek, M., & Cros, J. (2019). hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. Cancers, 11(11), . https://doi.org/10.3390/cancers11111808
Raffenne, Jerome, et al. "hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status." Cancers vol. 11,11 (2019). doi: https://doi.org/10.3390/cancers11111808
Raffenne J, Nicolle R, Puleo F, Le Corre D, Boyez C, Marechal R, Emile JF, Demetter P, Bardier A, Laurent-Puig P, de Mestier L, Paradis V, Couvelard A, VanLathem JL, MacKey JR, Bachet JB, Svrcek M, Cros J. hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 Status. Cancers (Basel). 2019 Nov 18;11(11). doi: 10.3390/cancers11111808. PMID: 31752123; PMCID: PMC6896053.
Copy Download .nbib Format: NLM
Solving modulated structures by X-ray and electron crystallography.

Micron (Oxford, England : 1993)

Caldes MT, Deniard P, Zou XD, Marchand R, Diot N, Brec R.
PMID: 11163723
Micron. 2001 Jul;32(5):497-507. doi: 10.1016/s0968-4328(00)00058-5.

X-ray diffraction can be used for accurately determining not only classical, ordinary structures, but also modulated ones. For structures with weak modulations, the modulation induced satellite reflections are often hard to be observed by X-ray diffraction, but they appear...

Cite
Caldes MT, Deniard P, Zou XD, et al. Solving modulated structures by X-ray and electron crystallography. Micron. 2001;32(5):497-507doi: 10.1016/s0968-4328(00)00058-5.
Caldes, M. T., Deniard, P., Zou, X. D., Marchand, R., Diot, N., & Brec, R. (2001). Solving modulated structures by X-ray and electron crystallography. Micron (Oxford, England : 1993), 32(5), 497-507. https://doi.org/10.1016/s0968-4328(00)00058-5
Caldes, M T, et al. "Solving modulated structures by X-ray and electron crystallography." Micron (Oxford, England : 1993) vol. 32,5 (2001): 497-507. doi: https://doi.org/10.1016/s0968-4328(00)00058-5
Caldes MT, Deniard P, Zou XD, Marchand R, Diot N, Brec R. Solving modulated structures by X-ray and electron crystallography. Micron. 2001 Jul;32(5):497-507. doi: 10.1016/s0968-4328(00)00058-5. PMID: 11163723.
Copy Download .nbib Format: NLM
Interim laboratory testing guidance for the detection of non-tuberculous Mycobacterium (NTM) infections in post-operative patients exposed to heater-cooler units.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Antonation K, Patel S, Waddell JT, Poliquin PG, Alexander DC, Hoang L, Farrell D, Garceau R, Haldane D, Jamieson F, Marchand R, MacKeen A, Marcino D, Theriault S, Tyrrell GJ, Zahariadis G, Zelyas N.
PMID: 29770044
Can Commun Dis Rep. 2017 Jan 05;43(1):25-28. doi: 10.14745/ccdr.v43i01a05. eCollection 2017 Jan 05.

The advice contained in this document should be read in conjunction with relevant federal, provincial, territorial and local legislation, regulations, and policies. Recommended measures should not be regarded as rigid standards, but principles and recommendations to inform the development...

Cite
Antonation K, Patel S, Waddell JT, et al. Interim laboratory testing guidance for the detection of non-tuberculous Mycobacterium (NTM) infections in post-operative patients exposed to heater-cooler units. Can Commun Dis Rep. 2017;43(1):25-28doi: 10.14745/ccdr.v43i01a05.
Antonation, K., Patel, S., Waddell, J. T., Poliquin, P. G., Alexander, D. C., Hoang, L., Farrell, D., Garceau, R., Haldane, D., Jamieson, F., Marchand, R., MacKeen, A., Marcino, D., Theriault, S., Tyrrell, G. J., Zahariadis, G., Zelyas, N. (2017). Interim laboratory testing guidance for the detection of non-tuberculous Mycobacterium (NTM) infections in post-operative patients exposed to heater-cooler units. Canada communicable disease report = Releve des maladies transmissibles au Canada, 43(1), 25-28. https://doi.org/10.14745/ccdr.v43i01a05
Antonation, K, et al. "Interim laboratory testing guidance for the detection of non-tuberculous Mycobacterium (NTM) infections in post-operative patients exposed to heater-cooler units." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 43,1 (2017): 25-28. doi: https://doi.org/10.14745/ccdr.v43i01a05
Antonation K, Patel S, Waddell JT, Poliquin PG, Alexander DC, Hoang L, Farrell D, Garceau R, Haldane D, Jamieson F, Marchand R, MacKeen A, Marcino D, Theriault S, Tyrrell GJ, Zahariadis G, Zelyas N. Interim laboratory testing guidance for the detection of non-tuberculous Mycobacterium (NTM) infections in post-operative patients exposed to heater-cooler units. Can Commun Dis Rep. 2017 Jan 05;43(1):25-28. doi: 10.14745/ccdr.v43i01a05. eCollection 2017 Jan 05. PMID: 29770044; PMCID: PMC5757725.
Copy Download .nbib Format: NLM
Parasites in Vietnam.

Parasitology today (Personal ed.)

Marchand R, Wright P.
PMID: 15275377
Parasitol Today. 1995 Feb;11(2):68-9. doi: 10.1016/0169-4758(95)80120-0.

No abstract available.

Cite
Marchand R, Wright P. Parasites in Vietnam. Parasitol Today. 1995;11(2):68-9doi: 10.1016/0169-4758(95)80120-0.
Marchand, R., & Wright, P. (1995). Parasites in Vietnam. Parasitology today (Personal ed.), 11(2), 68-9. https://doi.org/10.1016/0169-4758(95)80120-0
Marchand, R, and Wright, P. "Parasites in Vietnam." Parasitology today (Personal ed.) vol. 11,2 (1995): 68-9. doi: https://doi.org/10.1016/0169-4758(95)80120-0
Marchand R, Wright P. Parasites in Vietnam. Parasitol Today. 1995 Feb;11(2):68-9. doi: 10.1016/0169-4758(95)80120-0. PMID: 15275377.
Copy Download .nbib Format: NLM
Collagen-cliondroitin-6-sulfate hydrogel implants in CNS lesion cavities favor glial repair, the differentiation of co-implanted neurons and the growth of axons.

Restorative neurology and neuroscience

Woerly S, Marchand R.
PMID: 21551626
Restor Neurol Neurosci. 1991 Jan 01;3(2):95-9. doi: 10.3233/RNN-1991-3206.

Collagen chondroitin-6-sulfate hydrogels containing embryonic striatal neurons were implanted into premade brain cavities of the rat striatum. The bioimplant was progressively transformed into a new matrix mostly by the deposition of newly formed collagen and by the ingrowth of...

Cite
Woerly S, Marchand R. Collagen-cliondroitin-6-sulfate hydrogel implants in CNS lesion cavities favor glial repair, the differentiation of co-implanted neurons and the growth of axons. Restor Neurol Neurosci. 1991;3(2):95-9doi: 10.3233/RNN-1991-3206.
Woerly, S., & Marchand, R. (1991). Collagen-cliondroitin-6-sulfate hydrogel implants in CNS lesion cavities favor glial repair, the differentiation of co-implanted neurons and the growth of axons. Restorative neurology and neuroscience, 3(2), 95-9. https://doi.org/10.3233/RNN-1991-3206
Woerly, S, and Marchand, R. "Collagen-cliondroitin-6-sulfate hydrogel implants in CNS lesion cavities favor glial repair, the differentiation of co-implanted neurons and the growth of axons." Restorative neurology and neuroscience vol. 3,2 (1991): 95-9. doi: https://doi.org/10.3233/RNN-1991-3206
Woerly S, Marchand R. Collagen-cliondroitin-6-sulfate hydrogel implants in CNS lesion cavities favor glial repair, the differentiation of co-implanted neurons and the growth of axons. Restor Neurol Neurosci. 1991 Jan 01;3(2):95-9. doi: 10.3233/RNN-1991-3206. PMID: 21551626.
Copy Download .nbib Format: NLM
Comprehensive study of the valence band of standard alkali-metal and indium phosphorus oxide salts through x-ray photoemission spectroscopy and extended Hückel theory tight-binding analysis: A contribution towards the elucidation of local order in oxides on InP surfaces.

Physical review. B, Condensed matter

Agliz D, Chermette H, Le Beuze A, Lissillour R, Marchand R, Quemerais A.
PMID: 9947921
Phys Rev B Condens Matter. 1989 May 15;39(15):11055-11065. doi: 10.1103/physrevb.39.11055.

No abstract available.

Cite
Agliz D, Chermette H, Le Beuze A, et al. Comprehensive study of the valence band of standard alkali-metal and indium phosphorus oxide salts through x-ray photoemission spectroscopy and extended Hückel theory tight-binding analysis: A contribution towards the elucidation of local order in oxides on InP surfaces. Phys Rev B Condens Matter. 1989;39(15):11055-11065doi: 10.1103/physrevb.39.11055.
Agliz, D., Chermette, H., Le Beuze A, Lissillour, R., Marchand, R., & Quemerais, A. (1989). Comprehensive study of the valence band of standard alkali-metal and indium phosphorus oxide salts through x-ray photoemission spectroscopy and extended Hückel theory tight-binding analysis: A contribution towards the elucidation of local order in oxides on InP surfaces. Physical review. B, Condensed matter, 39(15), 11055-11065. https://doi.org/10.1103/physrevb.39.11055
Agliz, et al. "Comprehensive study of the valence band of standard alkali-metal and indium phosphorus oxide salts through x-ray photoemission spectroscopy and extended Hückel theory tight-binding analysis: A contribution towards the elucidation of local order in oxides on InP surfaces." Physical review. B, Condensed matter vol. 39,15 (1989): 11055-11065. doi: https://doi.org/10.1103/physrevb.39.11055
Agliz D, Chermette H, Le Beuze A, Lissillour R, Marchand R, Quemerais A. Comprehensive study of the valence band of standard alkali-metal and indium phosphorus oxide salts through x-ray photoemission spectroscopy and extended Hückel theory tight-binding analysis: A contribution towards the elucidation of local order in oxides on InP surfaces. Phys Rev B Condens Matter. 1989 May 15;39(15):11055-11065. doi: 10.1103/physrevb.39.11055. PMID: 9947921.
Copy Download .nbib Format: NLM
Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series.

European heart journal. Case reports

Leblon T, Riolet C, Ennezat P, Marechaux S.
PMID: 34993414
Eur Heart J Case Rep. 2021 Dec 16;6(1):ytab516. doi: 10.1093/ehjcr/ytab516. eCollection 2022 Jan.

BACKGROUND: Drug-induced valvular heart disease (DI-VHD) is a well-defined condition associated with specific pathology features. However, clinical presentations may broadly vary and thereby make DI-VHD diagnosis more challenging.CASE SUMMARY: We report two patients with a history of benfluorex administration,...

Cite
Leblon T, Riolet C, Ennezat P, et al. Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series. Eur Heart J Case Rep. 2021;6(1):ytab516doi: 10.1093/ehjcr/ytab516.
Leblon, T., Riolet, C., Ennezat, P., & Marechaux, S. (2022). Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series. European heart journal. Case reports, 6(1), ytab516. https://doi.org/10.1093/ehjcr/ytab516
Leblon, Tiphaine, et al. "Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series." European heart journal. Case reports vol. 6,1 (2022): ytab516. doi: https://doi.org/10.1093/ehjcr/ytab516
Leblon T, Riolet C, Ennezat P, Marechaux S. Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series. Eur Heart J Case Rep. 2021 Dec 16;6(1):ytab516. doi: 10.1093/ehjcr/ytab516. eCollection 2022 Jan. PMID: 34993414; PMCID: PMC8727063.
Copy Download .nbib Format: NLM
Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series.

European heart journal. Case reports

Leblon T, Riolet C, Ennezat P, Marechaux S.
PMID: 34993414
Eur Heart J Case Rep. 2021 Dec 16;6(1):ytab516. doi: 10.1093/ehjcr/ytab516. eCollection 2022 Jan.

BACKGROUND: Drug-induced valvular heart disease (DI-VHD) is a well-defined condition associated with specific pathology features. However, clinical presentations may broadly vary and thereby make DI-VHD diagnosis more challenging.CASE SUMMARY: We report two patients with a history of benfluorex administration,...

Cite
Leblon T, Riolet C, Ennezat P, et al. Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series. Eur Heart J Case Rep. 2021;6(1):ytab516doi: 10.1093/ehjcr/ytab516.
Leblon, T., Riolet, C., Ennezat, P., & Marechaux, S. (2022). Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series. European heart journal. Case reports, 6(1), ytab516. https://doi.org/10.1093/ehjcr/ytab516
Leblon, Tiphaine, et al. "Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series." European heart journal. Case reports vol. 6,1 (2022): ytab516. doi: https://doi.org/10.1093/ehjcr/ytab516
Leblon T, Riolet C, Ennezat P, Marechaux S. Caseous necrosis of the mitral annulus: a new feature of drug-induced valvular heart disease? Case series. Eur Heart J Case Rep. 2021 Dec 16;6(1):ytab516. doi: 10.1093/ehjcr/ytab516. eCollection 2022 Jan. PMID: 34993414; PMCID: PMC8727063.
Copy Download .nbib Format: NLM
Sex Hormones in Lymphedema.

Cancers

Morfoisse F, Zamora A, Marchaud E, Nougue M, Diallo LH, David F, Roussel E, Lacazette E, Prats AC, Tatin F, Garmy-Susini B.
PMID: 33573286
Cancers (Basel). 2021 Jan 30;13(3). doi: 10.3390/cancers13030530.

Lymphedema is a disorder of the lymphatic vascular system characterized by impaired lymphatic return resulting in swelling of the extremities and accumulation of undrained interstitial fluid/lymph that results in fibrosis and adipose tissue deposition in the limb. Whereas it...

Cite
Morfoisse F, Zamora A, Marchaud E, et al. Sex Hormones in Lymphedema. Cancers (Basel). 2021;13(3)doi: 10.3390/cancers13030530.
Morfoisse, F., Zamora, A., Marchaud, E., Nougue, M., Diallo, L. H., David, F., Roussel, E., Lacazette, E., Prats, A. C., Tatin, F., & Garmy-Susini, B. (2021). Sex Hormones in Lymphedema. Cancers, 13(3), . https://doi.org/10.3390/cancers13030530
Morfoisse, Florent, et al. "Sex Hormones in Lymphedema." Cancers vol. 13,3 (2021). doi: https://doi.org/10.3390/cancers13030530
Morfoisse F, Zamora A, Marchaud E, Nougue M, Diallo LH, David F, Roussel E, Lacazette E, Prats AC, Tatin F, Garmy-Susini B. Sex Hormones in Lymphedema. Cancers (Basel). 2021 Jan 30;13(3). doi: 10.3390/cancers13030530. PMID: 33573286; PMCID: PMC7866787.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 24 entries